Show items per page
Elements: 2
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models Deruaz, Maud; Bonvin, Pauline; Severin, India C; Johnson, Zoë; ... Proudfoot, Amanda E I 2013
add to browser selection
Preclinical development of a bispecific antibody that safely and effectively targets CD19 and CD47 for the treatment of B cell lymphoma and leukemia Buatois, Vanessa; Johnson, Zoë 2018